Laleh Razavi-Nematollahi1, Faramarz Ismail-Beigi2. 1. University Hospitals of Cleveland, Case Western Reserve University, 11100 Euclid Ave, Mather 1600, Cleveland, OH, 44106, USA. 2. Case Western Reserve University, 10900 Euclid Ave, Wood Building, W422, Cleveland, OH, 44106, USA. fxi2@case.edu.
Abstract
PURPOSE OF REVIEW: Treatment of patients with type 2 diabetes mellitus is focused on preventing the occurrence and delaying the development of macro- and micro-vascular complications. Glycemic control can help prevent these complications, but there is concern about the adverse effects of glycemia-lowering medications. A rational approach is to balance the desired low risk of adverse events against the unwanted higher risk of major complications resulting from suboptimal glucose control. RECENT FINDINGS: Using the above approach, approved glucose-lowering agents have favorable benefit-to-risk profiles for use in most patients with type 2 diabetes. We first briefly review the mechanism of actions and benefits of the different commonly used classes of glycemia-lowering medications and then discuss adverse effects and safety concern associated with their use. Our overall assessment is that if used appropriately, the different classes of glycemia-lowering medications offer beneficial outcomes with relatively modest and, in some instances, preventable adverse events.
PURPOSE OF REVIEW: Treatment of patients with type 2 diabetes mellitus is focused on preventing the occurrence and delaying the development of macro- and micro-vascular complications. Glycemic control can help prevent these complications, but there is concern about the adverse effects of glycemia-lowering medications. A rational approach is to balance the desired low risk of adverse events against the unwanted higher risk of major complications resulting from suboptimal glucose control. RECENT FINDINGS: Using the above approach, approved glucose-lowering agents have favorable benefit-to-risk profiles for use in most patients with type 2 diabetes. We first briefly review the mechanism of actions and benefits of the different commonly used classes of glycemia-lowering medications and then discuss adverse effects and safety concern associated with their use. Our overall assessment is that if used appropriately, the different classes of glycemia-lowering medications offer beneficial outcomes with relatively modest and, in some instances, preventable adverse events.
Authors: William M Steinberg; John B Buse; Marie Louise Muus Ghorbani; David D Ørsted; Michael A Nauck Journal: Diabetes Care Date: 2017-05-05 Impact factor: 19.112
Authors: A Tura; J I Bagger; E Ferrannini; J J Holst; F K Knop; T Vilsbøll; A Mari Journal: Nutr Metab Cardiovasc Dis Date: 2017-10-13 Impact factor: 4.222
Authors: Erland Erdmann; John A Dormandy; Bernard Charbonnel; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene Journal: J Am Coll Cardiol Date: 2007-04-16 Impact factor: 24.094
Authors: Kathleen M Dungan; Santiago Tofé Povedano; Thomas Forst; José G González González; Charles Atisso; Whitney Sealls; Jessie L Fahrbach Journal: Lancet Date: 2014-07-10 Impact factor: 79.321
Authors: Nelson B Watts; John P Bilezikian; Keith Usiskin; Robert Edwards; Mehul Desai; Gordon Law; Gary Meininger Journal: J Clin Endocrinol Metab Date: 2015-11-18 Impact factor: 5.958
Authors: Denise E Bonds; Michael E Miller; Richard M Bergenstal; John B Buse; Robert P Byington; Jeff A Cutler; R James Dudl; Faramarz Ismail-Beigi; Angela R Kimel; Byron Hoogwerf; Karen R Horowitz; Peter J Savage; Elizabeth R Seaquist; Debra L Simmons; William I Sivitz; Joann M Speril-Hillen; Mary Ellen Sweeney Journal: BMJ Date: 2010-01-08